Asia · Regional markets · FinanceAsia
Two Japan deep-tech startups complete Series B second closes
Helical Fusion and Celaid Therapeutics have raised JPY3.23bn and JPY400m, respectively, as Japanese capital increasingly targets research-intensive startups.
Read the full article on FinanceAsia Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.financeasia.com)


